Caris Life Sciences® , a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the commercial launch of Caris Detecttm, a groundbreaking ...
Source matters: Performance of guideline-anchored RAG versus broad evidence LLMs in GI oncology. This is an ASCO Meeting Abstract ...
Medicine has always operated as an “evidence based” field, meaning that it generally pursues experimentation to gather ...
Researchers at Mayo Clinic have developed an artificial intelligence (AI) system that could transform how pancreatic cancer ...
Research Says AI May Detect Breast Cancer Warning Signs Six Years Before Diagnosis ...
Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing by up to 3% annually. Diagnosis requires an often painful, invasive ...
PolyPEPI1018 Cancer Vaccine and TAS-102 for Patients With Advanced, Chemo-Refractory, Microsatellite-Stable Metastatic Colorectal ...